EUPRAXIA PHARMACEUTICALS INC. Proceeds from Interest Received
EUPRAXIA PHARMACEUTICALS INC. (EPRX) reported Proceeds from Interest Received of $1.41 million for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromInterestReceived · last filed 2026-03-13
| Period end | Proceeds from Interest Received 12 month |
|---|---|
| 2025-12-31 | $1.41M 40-F · filed 2026-03-13 |
| 2024-12-31 | $1.16M 40-F · filed 2026-03-13 |
| 2023-12-31 | $912.03K 40-F · filed 2025-03-20 |
| 2022-12-31 | $394.19K 40-F · filed 2024-04-01 |